StonvexLoading…
StonvexStonvexStonvexCore line items from EXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $129.48M | $120.86M | $101.99M | $83.90M |
Operating Income | $1.41B | $1.32B | $1.17B | $1.05B |
Net Income | $974.00M | $854.68M | $803.20M | $860.69M |
EPS (Diluted) | $4.59 | $4.03 | $4.74 | $6.41 |
Total Assets | $29.26B | $28.85B | $27.46B | $12.17B |
Total Liabilities | $14.94B | $13.99B | $12.04B | $8.09B |
Cash & Equivalents | $138.92M | $138.22M | $99.06M | $92.87M |
Free Cash Flow OCF − CapEx | $1.29B | $1.41B | $1.27B | $44.88M |
Shares Outstanding | 211.16M | 212.00M | 211.28M | 133.92M |